SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-040289
Filing Date
2022-07-19
Accepted
2022-07-19 16:06:57
Documents
2
Period of Report
2022-07-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea163026-6k_universepharm.htm 6-K 15962
2 UNIVERSE PHARMACEUTICALS INC RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID ea163026ex99-1_universepharm.htm EX-99.1 8621
  Complete submission text file 0001213900-22-040289.txt   25678
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 221091638
SIC: 2834 Pharmaceutical Preparations